75
Views
3
CrossRef citations to date
0
Altmetric
Original Research

LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells

, , ORCID Icon, , , , , ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 4551-4565 | Published online: 08 Sep 2021

References

  • Michiels C. Endothelial cell functions. J Cell Physiol. 2003;196:430–443. doi:10.1002/jcp.10333
  • Liberale L, Montecucco F, Schwarz L, Luscher TF, Camici GG. Inflammation and cardiovascular diseases: lessons from seminal clinical trials. Cardiovasc Res. 2021;117:411–422.
  • Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7:803–815. doi:10.1038/nri2171
  • Dinarello CA. Anti-inflammatory agents: present and future. Cell. 2010;140:935–950. doi:10.1016/j.cell.2010.02.043
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377:1119–1131. doi:10.1056/NEJMoa1707914
  • Samuel M, Tardif JC, Khairy P, et al. Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). Eur Heart J Qual Care Clin Outcomes. 2020;qcaa045. doi:10.1093/ehjqcco/qcaa045
  • Diamantis E, Kyriakos G, Quiles-Sanchez LV, Farmaki P, Troupis T. The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature. Curr Cardiol Rev. 2017;13:209–216. doi:10.2174/1573403X13666170426104611
  • Kosmas CE, Silverio D, Sourlas A, Montan PD, Guzman E, Garcia MJ. Anti-inflammatory therapy for cardiovascular disease. Ann Transl Med. 2019;7:147. doi:10.21037/atm.2019.02.34
  • Wen YT, Wu AT, Bamodu OA, et al. A novel multi-target small molecule, LCC-09, inhibits stemness and therapy-resistant phenotypes of glioblastoma cells by increasing miR-34a and deregulating the DRD4/Akt/mTOR signaling axis. Cancers. 2019;11:1442. doi:10.3390/cancers11101442
  • Lee CC, Liu Fl, Chen CL, Chen TC, Chang DM, Huang HS. Discovery of 5-(2ʹ,4ʹ-difluorophenyl)-salicylanilides as new inhibitors of receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis. Eur J Med Chem. 2015;98:115–126. doi:10.1016/j.ejmech.2015.05.015
  • Dai SP, Hsieh WS, Chen CH, et al. TDAG8 deficiency reduces satellite glial number and pro-inflammatory macrophage number to relieve rheumatoid arthritis disease severity and chronic pain. J Neuroinflammation. 2020;17:170. doi:10.1186/s12974-020-01851-z
  • Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC. Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J. 2016;37:1723–1732. doi:10.1093/eurheartj/ehv759
  • Zhang H, Park Y, Wu J, et al. Role of TNF-α in vascular dysfunction. Clin Sci (Lond). 2009;116:219–230. doi:10.1042/CS20080196
  • Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ. 2003;10:45–65.
  • Sedger LM, McDermott MF. TNF and TNF-receptors: from mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev. 2014;25:453–472.
  • Zhang C. The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol. 2008;103:398–406. doi:10.1007/s00395-008-0733-0
  • Cordero-Maldonado ML, Siverio-Mota D, Vicet-Muro L, et al. Optimization and pharmacological validation of a leukocyte migration assay in zebrafish larvae for the rapid in vivo bioactivity analysis of anti-inflammatory secondary metabolites. PLoS One. 2013;8:e75404. doi:10.1371/journal.pone.0075404
  • Renshaw SA, Trede NS. A model 450 million years in the making: zebrafish and vertebrate immunity. Dis Model Mech. 2012;5:38–47. doi:10.1242/dmm.007138
  • Ji B, Gaiser S, Chen X, Ernst SA, Logsdon CD. Intracellular trypsin induces pancreatic acinar cell death but not NF-κB activation. J Biol Chem. 2009;284(26):17488–17498. doi:10.1074/jbc.M109.005520
  • Westerfield M. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Brachydanio Rerio). University of Oregon press; 1993.
  • Renshaw SA, Loynes CA, Trushell DM, Elworthy S, Ingham PW, Whyte MK. A transgenic zebrafish model of neutrophilic inflammation. Blood. 2006;108:3976–3978. doi:10.1182/blood-2006-05-024075
  • Yang LL, Wang GQ, Yang LM, Huang ZB, Zhang WQ, Yu LZ. Endotoxin molecule lipopolysaccharide-induced zebrafish inflammation model: a novel screening method for anti-inflammatory drugs. Molecules. 2014;19:2390–2409. doi:10.3390/molecules19022390
  • Burns CG, Milan DJ, Grande EJ, Rottbauer W, MacRae CA, Fishman MC. High-throughput assay for small molecules that modulate zebrafish embryonic heart rate. Nat Chem Biol. 2005;1:263–264. doi:10.1038/nchembio732
  • Pober JS. Endothelial activation: intracellular signaling pathways. Arthritis Res. 2002;4(Suppl 3):S109–S116. doi:10.1186/ar576
  • Dore M, Sirois J. Regulation of P-selectin expression by inflammatory mediators in canine jugular endothelial cells. Vet Pathol. 1996;33:662–671. doi:10.1177/030098589603300605
  • Mako V, Czucz J, Weiszhar Z, et al. Proinflammatory activation pattern of human umbilical vein endothelial cells induced by IL-1beta, TNF-alpha, and LPS. Cytometry A. 2010;77:962–970. doi:10.1002/cyto.a.20952
  • Mehta NN, Teague HL, Swindell WR, et al. IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis. Sci Rep. 2017;7:13831. doi:10.1038/s41598-017-14365-1
  • Schindler U, Baichwal VR. Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression. Mol Cell Biol. 1994;14:5820–5831.
  • Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2292–2301. doi:10.1161/ATVBAHA.107.149179
  • Smith CW. Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol. 1993;71:76–87. doi:10.1139/y93-012
  • Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res. 2007;101:234–247. doi:10.1161/CIRCRESAHA.107.151860b
  • Chen X, Andresen BT, Hill M, Zhang J, Booth F, Zhang C. Role of reactive oxygen species in tumor necrosis factor-alpha induced endothelial dysfunction. Curr Hypertens Rev. 2008;4:245–255. doi:10.2174/157340208786241336
  • Philip AM, Wang Y, Mauro A, et al. Development of a zebrafish sepsis model for high-throughput drug discovery. Mol Med. 2017;23:134–148. doi:10.2119/molmed.2016.00188
  • Forn-Cuni G, Varela M, Pereiro P, Novoa B, Figueras A. Conserved gene regulation during acute inflammation between zebrafish and mammals. Sci Rep. 2017;7:41905. doi:10.1038/srep41905
  • Jin Y, Xu Z, Yan H, He Q, Yang X, Luo P. A comprehensive review of clinical cardiotoxicity incidence of FDA-approved small-molecule kinase inhibitors. Front Pharmacol. 2020;11:891. doi:10.3389/fphar.2020.00891
  • Zakaria ZZ, Benslimane FM, Nasrallah GK, et al. Using zebrafish for investigating the molecular mechanisms of drug-induced cardiotoxicity. Biomed Res Int. 2018;2018:1642684. doi:10.1155/2018/1642684
  • Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159–175. doi:10.1038/nri3399
  • Granger DN, Vowinkel T, Petnehazy T. Modulation of the inflammatory response in cardiovascular disease. Hypertension. 2004;43:924–931. doi:10.1161/01.HYP.0000123070.31763.55
  • Ley K, Allietta M, Bullard DC, Morgan S. Importance of E-selectin for firm leukocyte adhesion in vivo. Circ Res. 1998;83:287–294. doi:10.1161/01.RES.83.3.287
  • Silva M, Videira PA, Sackstein R. E-selectin ligands in the human mononuclear phagocyte system: implications for infection, inflammation, and immunotherapy. Front Immunol. 2017;8:1878. doi:10.3389/fimmu.2017.01878
  • Venkatesh D, Ernandez T, Rosetti F, et al. Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment. Immunity. 2013;38(5):1025–1037. doi:10.1016/j.immuni.2013.01.012
  • Kunkel EJ, Ley K. Distinct phenotype of E-selectin-deficient mice: E-selectin is required for slow leukocyte rolling in vivo. Circ Res. 1996;79:1196–1204. doi:10.1161/01.RES.79.6.1196
  • Su Y, Lei X, Wu L, Liu L. The role of endothelial cell adhesion molecules P-selectin, E-selectin and intercellular adhesion molecule-1 in leucocyte recruitment induced by exogenous methylglyoxal. Immunology. 2012;137:65–79. doi:10.1111/j.1365-2567.2012.03608.x
  • Yu Y, Moulton KS, Khan MK, et al. E-selectin is required for the antiangiogenic activity of endostatin. Proc Natl Acad Sci U S A. 2004;101:8005–8010. doi:10.1073/pnas.0402551101
  • Rodriguez-Romero A, Almog O, Tordova M, Randhawa Z, Gilliland GL. Primary and tertiary structures of the Fab fragment of a monoclonal anti-E-selectin 7A9 antibody that inhibits neutrophil attachment to endothelial cells. J Biol Chem. 1998;273:11770–11775. doi:10.1074/jbc.273.19.11770
  • Muller WA. How endothelial cells regulate transmigration of leukocytes in the inflammatory response. Am J Pathol. 2014;184:886–896. doi:10.1016/j.ajpath.2013.12.033
  • Vestweber D. How leukocytes cross the vascular endothelium. Nat Rev Immunol. 2015;15:692–704. doi:10.1038/nri3908
  • Nelson DE, Ihekwaba AE, Elliott M, et al. Oscillations in NF-kappaB signaling control the dynamics of gene expression. Science. 2004;306:704–708. doi:10.1126/science.1099962
  • Hoffmann A, Levchenko A, Scott ML, Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science. 2002;298:1241–1245. doi:10.1126/science.1071914
  • Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol. 2008;9:378–387. doi:10.1038/ni1576
  • Sepulcre MP, Alcaraz-Perez F, Lopez-Munoz A, et al. Evolution of lipopolysaccharide (LPS) recognition and signaling: fish TLR4 does not recognize LPS and negatively regulates NF-κB activation. J Immunol. 2009;182:1836–1845. doi:10.4049/jimmunol.0801755
  • Kempe S, Kestler H, Lasar A, Wirth T. NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program. Nucleic Acids Res. 2005;33:5308–5319. doi:10.1093/nar/gki836
  • Kalliolias GD, Ivashkiv LB. TNF biology, pathogenic mechanisms and emerging therapeutic strategies. Nat Rev Rheumatol. 2016;12:49–62. doi:10.1038/nrrheum.2015.169
  • Laug R, Fehrholz M, Schutze N, et al. IFN-γ and TNF-α synergize to inhibit CTGF expression in human lung endothelial cells. PLoS One. 2012;7:e45430. doi:10.1371/journal.pone.0045430
  • Yarilina A, Xu K, Chan C, Ivashkiv LB. Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors. Arthritis Rheum. 2012;64:3856–3866. doi:10.1002/art.37691
  • Barczewski AH, Ragusa MJ, Mierke DF, Pellegrini M. The IKK-binding domain of NEMO is an irregular coiled coil with a dynamic binding interface. Sci Rep. 2019;9:2950. doi:10.1038/s41598-019-39588-2
  • Rushe M, Silvian L, Bixler S, et al. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site. Structure. 2008;16:798–808. doi:10.1016/j.str.2008.02.012
  • Rhodes CA, Dougherty PG, Cooper JK, et al. Cell-permeable bicyclic peptidyl inhibitors against NEMO-IκB kinase interaction directly from a combinatorial library. J Am Chem Soc. 2018;140:12102–12110. doi:10.1021/jacs.8b06738
  • Harrison DA. The Jak/STAT pathway. Cold Spring Harb Perspect Biol. 2012;4:a011205. doi:10.1101/cshperspect.a011205
  • Bousoik E, Montazeri Aliabadi H. “Do we know jack” about JAK? A closer look at JAK/STAT signaling pathway. Front Oncol. 2018;8:287.
  • Guo D, Dunbar JD, Yang CH, Pfeffer LM, Donner DB. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol. 1998;160:2742–2750.
  • Ghoreschi K, Jesson MI, Li X, et al. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol. 2011;186:4234–4243. doi:10.4049/jimmunol.1003668
  • Kim LC, Song L, Haura EB. Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol. 2009;6:587–595. doi:10.1038/nrclinonc.2009.129
  • Vignais ML, Sadowski HB, Watling D, Rogers NC, Gilman M. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol. 1996;16:1759–1769. doi:10.1128/MCB.16.4.1759
  • Pierce JW, Read MA, Ding H, Luscinskas FW, Collins T. Salicylates inhibit I kappa B-alpha phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol. 1996;156:3961–3969.
  • Gerli R, Paolucci C, Gresele P, et al. Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells. Blood. 1998;92:2389–2398. doi:10.1182/blood.V92.7.2389
  • Shirakawa K, Wang L, Man N, et al. Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. Elife. 2016;5:e11156. doi:10.7554/eLife.11156
  • Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 1994;265:956–959. doi:10.1126/science.8052854
  • Hauser TH, Salastekar N, Schaefer EJ, et al. Effect of targeting inflammation with salsalate: the TINSAL-CVD randomized clinical trial on progression of coronary plaque in overweight and obese patients using statins. JAMA Cardiol. 2016;1:413–423. doi:10.1001/jamacardio.2016.0605
  • Nohria A, Kinlay S, Buck JS, et al. The effect of salsalate therapy on endothelial function in a broad range of subjects. J Am Heart Assoc. 2014;3:e000609. doi:10.1161/JAHA.113.000609
  • Vinsova J, Imramovsky A, Buchta V, et al. Salicylanilide acetates: synthesis and antibacterial evaluation. Molecules. 2007;12:1–12. doi:10.3390/12010001
  • Hu M, Ye W, Li J, Zhou P, Chu Z, Huang W. The salicylanilide derivatives inhibit signal transducer and activator of transcription 3 pathways in A549 lung cancer cells. Anticancer Drugs. 2016;27:41–47. doi:10.1097/CAD.0000000000000303